PLYMOUTH MEETING, Pa., Oct. 23, 2025 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases, today announced that it will participate in a virtual fireside chat at the upcoming Stephens Biotechnology Virtual Fireside Chat Conference. During the conference, members of INOVIO's management team will also be conducting one-on-one meetings with investors.
Date: November 4, 2025
Time: 3:00-3:50pm ET
Format: Virtual fireside chat
There will not be a replay or transcript of the call(s). To join the meetings or to obtain more information, please contact your Stephens representative.
About INOVIO
INOVIO is a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases. INOVIO's technology optimizes the design and delivery of innovative DNA medicines that teach the body to manufacture its own disease-fighting tools. For more information, visit www.inovio.com.
Contacts
Media: Jennie Willson, (267) 429-8567, This email address is being protected from spambots. You need JavaScript enabled to view it.
Investors: Peter Vozzo, ICR Healthcare, (443) 213-0505, This email address is being protected from spambots. You need JavaScript enabled to view it.

| Last Trade: | US$2.15 |
| Daily Change: | 0.03 1.42 |
| Daily Volume: | 2,634,700 |
| Market Cap: | US$114.250M |
November 10, 2025 November 10, 2025 November 03, 2025 October 21, 2025 August 26, 2025 | |

Amneal Pharmaceuticals is a fully-integrated essential medicines company. We make healthy possible through the development, manufacturing, and distribution of generic and specialty pharmaceuticals. The Company has a diverse portfolio of over 250 products in its Generics segment and is expanding across...
CLICK TO LEARN MORE
Recursion Pharmaceuticals is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest....
CLICK TO LEARN MOREEnd of content
No more pages to load